Search Results for "captopril"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for captopril. Results 1 to 4 of 4 total matches.
Comparison Table: Some Drugs for HFrEF (online only)
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
inhibitor can cause severe leukopenia and anemia
Captopril is a substrate of CYP2D6; use with a CYP2D6 ...
View the Comparison Table: Some Drugs for HFrEF
Drugs Past Their Expiration Date
The Medical Letter on Drugs and Therapeutics • Jul 27, 2020 (Issue 1603)
the degradation of some drug formulations, but in
one study, captopril tablets, theophylline tablets ...
Healthcare providers are often asked if drugs can
be used past their expiration date. Because of legal
restrictions and liability concerns, manufacturers do
not sanction such use and usually do not comment
on the safety or effectiveness of their products beyond
the date on the label. Since our last article on this
subject, more data have become available.
Drugs for Chronic Heart Failure
The Medical Letter on Drugs and Therapeutics • Jun 14, 2021 (Issue 1626)
Angiotensin-Converting Enzyme (ACE) Inhibitors
Captopril – generic 12.5, 25, 50, 100 mg tabs4 6.25 mg tid 50 ...
Among patients with chronic heart failure, those with
a left ventricular ejection fraction (LVEF) ≤40% are
considered to have heart failure with reduced ejection
fraction (HFrEF). Patients with a LVEF ≥50% are
considered to have heart failure with preserved ejection
fraction (HFpEF). Those with a LVEF of 41-49% are an
intermediate group more similar to patients with HFpEF.
Drugs for Hypertension
The Medical Letter on Drugs and Therapeutics • May 27, 2024 (Issue 1703)
dyscrasias
and renal damage
(particularly in patients with
renal dysfunction)
Captopril – generic 12.5 ...
American College of Cardiology/American Heart
Association (ACC/AHA) guidelines for treatment of
hypertension were last published in 2018. Treatment
of hypertensive urgencies and emergencies is not
discussed here.
Med Lett Drugs Ther. 2024 May 27;66(1703):81-8 doi:10.58347/tml.2024.1703a | Show Introduction Hide Introduction